Journal Published Online: 01 January 1999
Volume 44, Issue 1

A Fatality Due to the Intranasal Abuse of Methylphenidate (Ritalin®)



A fatality in a teenager from the recreational intranasal abuse of methylphenidate (Ritalin®) is reported. The prescribed use of methylphenidate (Ritalin®) in the treatment of attention deficit and/or hyperactivity disorder is widespread. The intranasal abuse of methylphenidate (Ritalin®) among teenagers is becoming increasingly more recognized. Previous deaths from the parenteral abuse of methylphenidate (Ritalin®) have been reported. This fatality is the first reported from its intranasal abuse.

Author Information

Massello, W
Office of the Chief Medical Examiner, Commonwealth of Virginia, Roanoke, VA
Carpenter, DA
Alabama Department of Forensic Sciences, Paul Shoffeitt Laboratories, Birmingham, AL
Pages: 2
Price: $25.00
Reprints and Permissions
Reprints and copyright permissions can be requested through the
Copyright Clearance Center
Stock #: JFS14440J
ISSN: 0022-1198
DOI: 10.1520/JFS14440J